Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
|Articles|May 1, 2008
- Volume 0 0
advertiserINDEX
Advertisement
Articles in this issue
over 18 years ago
productHOTLINEover 18 years ago
Motion Sickness: Calming the Waves of Upsetover 18 years ago
pharmacy Pet Peevesover 18 years ago
recruitment/RESOURCESover 18 years ago
canyouREADtheseRxs?over 18 years ago
Case Studiesover 18 years ago
DIABETESWATCHover 18 years ago
CHOLESTEROLWATCHover 18 years ago
compoundingHOTLINEover 18 years ago
ARTHRITISWATCHAdvertisement
Related to this article
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
2
Pneumonic Plague: What Pharmacists Need to Know About Treatment
3
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
4
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
5